Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This is a study about treatment for people who suffer from both major depression and alcohol
abuse or dependence. The study will examine whether the addition of acamprosate to
escitalopram and behavioral interventions will improve outcomes for this population.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Alliance for Research on Schizophrenia and Depression